These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 33849281

  • 1. Biomarker-Based Risk Prediction With the ABC-AF Scores in Patients With Atrial Fibrillation Not Receiving Oral Anticoagulation.
    Benz AP, Hijazi Z, Lindbäck J, Connolly SJ, Eikelboom JW, Oldgren J, Siegbahn A, Wallentin L.
    Circulation; 2021 May 11; 143(19):1863-1873. PubMed ID: 33849281
    [Abstract] [Full Text] [Related]

  • 2. Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time.
    Hijazi Z, Lindahl B, Oldgren J, Andersson U, Lindbäck J, Granger CB, Alexander JH, Gersh BJ, Hanna M, Harjola VP, Hylek EM, Lopes RD, Siegbahn A, Wallentin L.
    J Am Heart Assoc; 2017 Jun 23; 6(6):. PubMed ID: 28645934
    [Abstract] [Full Text] [Related]

  • 3. A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score.
    Hijazi Z, Oldgren J, Lindbäck J, Alexander JH, Connolly SJ, Eikelboom JW, Ezekowitz MD, Held C, Hylek EM, Lopes RD, Yusuf S, Granger CB, Siegbahn A, Wallentin L, ARISTOTLE and RE-LY Investigators.
    Eur Heart J; 2018 Feb 07; 39(6):477-485. PubMed ID: 29069359
    [Abstract] [Full Text] [Related]

  • 4. Heart Failure Risk Assessment Using Biomarkers in Patients With Atrial Fibrillation: Analysis From COMBINE-AF.
    Haller PM, Jarolim P, Palazzolo MG, Bellavia A, Antman EM, Eikelboom J, Granger CB, Harrington J, Healey JS, Hijazi Z, Patel MR, Patel SM, Ruff CT, Wallentin L, Braunwald E, Giugliano RP, Morrow DA.
    J Am Coll Cardiol; 2024 Oct 15; 84(16):1528-1540. PubMed ID: 39230543
    [Abstract] [Full Text] [Related]

  • 5. Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation.
    Oldgren J, Hijazi Z, Lindbäck J, Alexander JH, Connolly SJ, Eikelboom JW, Ezekowitz MD, Granger CB, Hylek EM, Lopes RD, Siegbahn A, Yusuf S, Wallentin L, RE-LY and ARISTOTLE Investigators.
    Circulation; 2016 Nov 29; 134(22):1697-1707. PubMed ID: 27569438
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas.
    Pol T, Hijazi Z, Lindbäck J, Alexander JH, Bahit MC, De Caterina R, Eikelboom JW, Ezekowitz MD, Gersh BJ, Granger CB, Hylek EM, Lopes R, Siegbahn A, Wallentin L.
    Open Heart; 2021 Mar 29; 8(1):. PubMed ID: 33741689
    [Abstract] [Full Text] [Related]

  • 7. Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48.
    Berg DD, Ruff CT, Jarolim P, Giugliano RP, Nordio F, Lanz HJ, Mercuri MF, Antman EM, Braunwald E, Morrow DA.
    Circulation; 2019 Feb 05; 139(6):760-771. PubMed ID: 30586727
    [Abstract] [Full Text] [Related]

  • 8. Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation.
    Sharma A, Hijazi Z, Andersson U, Al-Khatib SM, Lopes RD, Alexander JH, Held C, Hylek EM, Leonardi S, Hanna M, Ezekowitz JA, Siegbahn A, Granger CB, Wallentin L.
    Circulation; 2018 Oct 16; 138(16):1666-1676. PubMed ID: 29871978
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the Age, Biomarkers, and Clinical History-Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials.
    Hijazi Z, Oldgren J, Lindbäck J, Alexander JH, Alings M, De Caterina R, Eikelboom JW, Ezekowitz MD, Held C, Huber K, Hylek EM, Granger CB, Lopes RD, Vinereanu D, Siegbahn A, Wallentin L.
    JAMA Netw Open; 2020 Sep 01; 3(9):e2015943. PubMed ID: 32936298
    [Abstract] [Full Text] [Related]

  • 10. Neurofilament Light Chain and Risk of Stroke in Patients With Atrial Fibrillation.
    Aulin J, Sjölin K, Lindbäck J, Benz AP, Eikelboom JW, Hijazi Z, Kultima K, Oldgren J, Wallentin L, Burman J, ACTIVE A and AVERROES Investigators.
    Circulation; 2024 Oct 01; 150(14):1090-1100. PubMed ID: 39045686
    [Abstract] [Full Text] [Related]

  • 11. The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study.
    Hijazi Z, Oldgren J, Lindbäck J, Alexander JH, Connolly SJ, Eikelboom JW, Ezekowitz MD, Held C, Hylek EM, Lopes RD, Siegbahn A, Yusuf S, Granger CB, Wallentin L, ARISTOTLE and RE-LY Investigators.
    Lancet; 2016 Jun 04; 387(10035):2302-2311. PubMed ID: 27056738
    [Abstract] [Full Text] [Related]

  • 12. Prediction of Incident Atrial Fibrillation in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort Study.
    Zelnick LR, Shlipak MG, Soliman EZ, Anderson A, Christenson R, Lash J, Deo R, Rao P, Afshinnia F, Chen J, He J, Seliger S, Townsend R, Cohen DL, Go A, Bansal N.
    Clin J Am Soc Nephrol; 2021 Jul 04; 16(7):1015-1024. PubMed ID: 34597264
    [Abstract] [Full Text] [Related]

  • 13. Growth Differentiation Factor-15 Based ABC (Age, Biomarkers, Clinical History)-AF (Atrial Fibrillation)-Bleeding Risk Score for Elderly Patients with Nonvalvular Atrial Fibrillation.
    O UF, Chong TK, Wei Y, Lo CI, Wu W.
    J Healthc Eng; 2022 Jul 04; 2022():2863815. PubMed ID: 35299688
    [Abstract] [Full Text] [Related]

  • 14. ABC-AF-Stroke score predicts thromboembolism in non-anticoagulated patients following successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry.
    Wang Y, Jiang C, He L, Du X, Guo X, Tang R, Sang C, Long D, Dong J, Hijazi Z, Lip GYH, Ma C.
    Chin Med J (Engl); 2023 Oct 20; 136(20):2451-2458. PubMed ID: 37858319
    [Abstract] [Full Text] [Related]

  • 15. Supraventricular arrhythmia, N-terminal pro-brain natriuretic peptide and troponin T concentration in relation to incidence of atrial fibrillation: a prospective cohort study.
    Xiao J, Persson AP, Engström G, Johnson LSB.
    BMC Cardiovasc Disord; 2021 Mar 12; 21(1):134. PubMed ID: 33711943
    [Abstract] [Full Text] [Related]

  • 16. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
    Roldán V, Vílchez JA, Manzano-Fernández S, Jover E, Gálvez J, Puche CM, Valdés M, Vicente V, Lip GY, Marín F.
    Stroke; 2014 Mar 12; 45(3):696-701. PubMed ID: 24519407
    [Abstract] [Full Text] [Related]

  • 17. B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies.
    Sinner MF, Stepas KA, Moser CB, Krijthe BP, Aspelund T, Sotoodehnia N, Fontes JD, Janssens AC, Kronmal RA, Magnani JW, Witteman JC, Chamberlain AM, Lubitz SA, Schnabel RB, Vasan RS, Wang TJ, Agarwal SK, McManus DD, Franco OH, Yin X, Larson MG, Burke GL, Launer LJ, Hofman A, Levy D, Gottdiener JS, Kääb S, Couper D, Harris TB, Astor BC, Ballantyne CM, Hoogeveen RC, Arai AE, Soliman EZ, Ellinor PT, Stricker BH, Gudnason V, Heckbert SR, Pencina MJ, Benjamin EJ, Alonso A.
    Europace; 2014 Oct 12; 16(10):1426-33. PubMed ID: 25037055
    [Abstract] [Full Text] [Related]

  • 18. The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation.
    Hijazi Z, Lindbäck J, Alexander JH, Hanna M, Held C, Hylek EM, Lopes RD, Oldgren J, Siegbahn A, Stewart RA, White HD, Granger CB, Wallentin L, ARISTOTLE and STABILITY Investigators.
    Eur Heart J; 2016 May 21; 37(20):1582-90. PubMed ID: 26920728
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.